Company Filing History:
Years Active: 2003
Title: The Innovative Contributions of Michael Riedy in Genetic Research
Introduction
Michael Riedy, an esteemed inventor based in San Diego, CA, has made significant contributions to the field of genetics with his focused research on the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene. His innovative work revolves around identifying genetic polymorphisms that affect drug metabolism and interaction, making him a notable figure in the world of genetic research and patenting.
Latest Patents
Riedy holds a patent titled "Genotyping the human UDP-glucuronosyltransferase 2B7 (UGT2B7) gene." This groundbreaking patent identifies genetic variations in the UGT2B4, UGT2B7, and UGT2B15 genes that influence UGT2B activity. The patent outlines the use of nucleic acids containing polymorphic sequences to screen patients for altered metabolism of UGT2B substrates, potential drug-drug interactions, and adverse side effects. Additionally, these nucleic acids facilitate the establishment of animal, cell, and in vitro models crucial for drug metabolism studies.
Career Highlights
Michael Riedy is currently affiliated with Dna Sciences Laboratories, Inc., where he continues to apply his expertise in genetics to advance research in personalized medicine. His work has important implications for understanding how genetic factors can influence individual responses to drugs, thereby improving therapeutic outcomes and minimizing risks.
Collaborations
Throughout his career, Riedy has worked alongside talented colleagues, including Margaret Galvin and Andrew Miller. These collaborations have enriched his research efforts, fostering an environment of innovative thinking and shared knowledge, crucial for advancing genetic research and its applications.
Conclusion
Michael Riedy's contributions to genetic research, particularly his patent on the UGT2B7 gene, highlight the importance of innovation in understanding drug metabolism and interactions. His work not only contributes to the scientific community but also holds the promise of improving patient care through personalized medicine, showcasing the vital role of inventors in driving progress in healthcare and genetics.